RAPT Therapeutics (RAPT) Q2 2023 Earnings

11AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.8
-0.74
-0.69
-0.63

Details

Expected EPS
-0.8
Actual EPS
-0.66
Surprise EPS
0.14
Surprise Percent
+17.5%

Description

RAPT Therapeutics (RAPT) has reported earnings of -0.66 per share for Q2 2023.

0 Comments

Share your thoughts